Search - tctmd.com

Displaying 881 - 900 of 923

Sort: Relevancy | Date

Presentation TCT 2012

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Presenter: Martyn Thomas

October 23, 2012

News Daily News

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

L.A. McKeown

October 23, 2012

Presentation TCT 2012

Functional MR Due to Idiopathic vs. Ischemic Cardiomyopathy (and Due to Anterior vs. Posterior Infarction): Similarities and Differences

Presenter: Blase Carabello

October 23, 2012

News Daily News

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

L.A. McKeown

October 23, 2012

Presentation TCT 2012

CHF and Cardiomyopathy

Presenter: Michael Kim

October 21, 2012

Presentation

Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Presenter: Paul Sorajja

October 19, 2012

Presentation ACVS 2012

Interventional Treatment of HOCM: Overview of Techniques and Results

Presenter: Rajeev Lochan

August 03, 2012

News Daily News

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

July 19, 2012

News Industry News

CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure

May 18, 2012

News Daily News

Several Factors Behind False-Positive STEMI Activations

Yael L. Maxwell

May 09, 2012

Presentation Fellows 2012

Hypertrophic Cardiomyopathy and Alcohol Septal Ablation

Presenter: Srihari Naidu

April 22, 2012

News Daily News

SCIPIO: El Tratamiento con Células Madre Cardíacas Parece Prometedor a la luz de los Resultados Preliminares

Yael L. Maxwell

March 08, 2012

News Daily News

SCIPIO: Cardiac Stem Cell Treatment Looks Promising in Early Results

Yael L. Maxwell

March 08, 2012

News Daily News

Cardiac Stem Cell Therapy Safe, May Regenerate Heart Tissue

Caitlin E. Cox

March 06, 2012

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

Presentation Cell Therapy 2012

REVIVE: Early Results of Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

Presenter: Amit Patel

January 25, 2012

Presentation TCT 2012

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Presenter: Paul S. Rees, Sean M. Davidson, Sian E. Harding, Perry M. Elliott, Derek J. Hausenloy, Derek M. Yellon

January 03, 2012

Presentation TCT 2012

Impact of the Different Route of Cell Delivery in Chronic Ischemic Cardiomyopathy Ovine Model

Presenter: Yanping Cheng, Geng-Hua Yi, Armando Tellez, Greg L. Kaluza, Juan F. Granada

January 03, 2012

News Industry News

Quality of life benefits of transcatheter aortic valve replacement differ by access site

November 09, 2011

News Industry News

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

November 09, 2011

Advertisement

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

Functional MR Due to Idiopathic vs. Ischemic Cardiomyopathy (and Due to Anterior vs. Posterior Infarction): Similarities and Differences

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

CHF and Cardiomyopathy

Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Interventional Treatment of HOCM: Overview of Techniques and Results

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure

Several Factors Behind False-Positive STEMI Activations

Hypertrophic Cardiomyopathy and Alcohol Septal Ablation

SCIPIO: El Tratamiento con Células Madre Cardíacas Parece Prometedor a la luz de los Resultados Preliminares

SCIPIO: Cardiac Stem Cell Treatment Looks Promising in Early Results

Cardiac Stem Cell Therapy Safe, May Regenerate Heart Tissue

Novel Strategies Advance Cell Therapy for Cardiomyopathy

REVIVE: Early Results of Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Impact of the Different Route of Cell Delivery in Chronic Ischemic Cardiomyopathy Ovine Model

Quality of life benefits of transcatheter aortic valve replacement differ by access site

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content